mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.3 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.3 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.3 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.3 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.3 |